Phase II study of the oral selective inhibitor of nuclear export (SINE) KPT-335 (verdinexor) in dogs with lymphoma
Sadowski, Abbey R., Gardner, Heather L., Borgatti, Antonella, Wilson, Heather, Vail, David M., Lachowicz, Joshua, Manley, Christina, Turner, Avenelle, Klein, Mary K., Waite, Angharad, Sahora, AlexandrVolume:
14
Langue:
english
Journal:
BMC Veterinary Research
DOI:
10.1186/s12917-018-1587-9
Date:
December, 2018
Fichier:
PDF, 560 KB
english, 2018